Similarly, we have reduced onset of hyperglycemia in NOD mice after regulated delivery of IL-4 to pancreatic β cells in vivo using an adenoassociated vector (AAV) expressing IL-4 under the control of the mouse insulin promoter [5]. The gene discussed is IL4; the disease is Hyperglycemia.